Automated stereocontrolled assembly-line synthesis

Technology
In market
University
Scouted & summarized by Halo AI

A fully automated, robotic platform for the stereocontrolled assembly-line synthesis of complex organic molecules. This technology enables iterative carbon-carbon bond formation with high precision, accelerating the development and production of advanced molecular building blocks and high-value small molecules for pharmaceutical and chemical applications.

Overview

The automated stereocontrolled assembly-line synthesis is a robotic platform-based method that enables the iterative, highly precise construction of complex organic molecules. By mimicking natural biosynthetic pathways, this technology allows for the automated formation of C(sp3)–C(sp3) bonds with exceptional stereochemical control and reproducibility. This approach significantly accelerates the production of advanced molecular building blocks and complex small molecules, providing a scalable, robust alternative to traditional manual synthetic routes.

Technical specifications
  • Capability for iterative, multi-step carbon-carbon bond formation (including up to six sequential one-carbon homologations).
  • High stereochemical fidelity and precision, enabling the synthesis of molecules with tailored shapes and specific stereochemistry.
  • Fully automated platform based on a Chemspeed SWING workstation, capable of handling air- and moisture-sensitive reagents under inert conditions.
  • Integrated capabilities for automated functional-group manipulations, purification (catch-and-release), and reaction optimization.
  • Temperature control range from -70 °C to 120 °C, supporting a wide variety of synthetic protocols.
  • Automated sampling and analytical integration, including off-line LC-MS and NMR compatibility for real-time monitoring and verification.
Technology readiness level

The technology is at TRL 7. It has been validated through published research studies, including the successful synthesis of complex natural products like (+)-kalkitoxin using a commercial robotic platform (Chemspeed). The system is operational within a research facility and has demonstrated reproducible, high-performance results in challenging synthetic scenarios.

Generated Aug 27, 2026. Please verify key information.

About University of Bristol

The University of Bristol is a comprehensive Russell Group research university with a strong record of collaborating with industry on translational R&D. Its new Temple Quarter Enterprise Campus provides shared labs, demonstrator environments, and a single front door for companies through Bristol Innovations. SETsquared Bristol—based at the Engine Shed—accelerates venture creation and connects corporates to a pipeline of startups and spin‑outs. Healthcare collaboration is embedded through strategic partnerships with regional NHS trusts, including the NIHR Bristol Biomedical Research Centre, enabling clinical translation at scale. Research is supported by competitive funding from UKRI councils and the National Institute for Health and Care Research, alongside industry partnerships.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.